Acthar for Treatment-Resistant or Treatment-Intolerant Proteinuria
Public ClinicalTrials.gov record NCT02633046. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic Focal Segmental Glomerulosclerosis: A Prospective Study of Acthar (PODOCYTE)
Study identification
- NCT ID
- NCT02633046
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Mallinckrodt ARD LLC
- Industry
- Enrollment
- 63 participants
Conditions and interventions
Interventions
- Acthar Gel Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 9, 2016
- Primary completion
- Aug 26, 2020
- Completion
- Aug 26, 2020
- Last update posted
- Aug 3, 2021
2016 – 2020
United States locations
- U.S. sites
- 21
- U.S. states
- 15
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| AKDHC Medical Research Services, LLC | Tucson | Arizona | 85712 | — |
| California Institute of Renal Research | Chula Vista | California | 91910 | — |
| Stanford University | Stanford | California | 94305 | — |
| VERITAS Research Corp | Miami Lakes | Florida | 33014 | — |
| Genesis Clinical Research Corp | Tampa | Florida | 33614 | — |
| GA Nephrology | Lawrenceville | Georgia | 30046 | — |
| NANI Research | Hinsdale | Illinois | 60521 | — |
| University of Louisville Research Foundation, Inc. | Louisville | Kentucky | 40202 | — |
| Ochsner Clinic Foundation, Baton Rouge | Baton Rouge | Louisiana | 70809 | — |
| NKDHC Medical Research Services, LLC | Las Vegas | Nevada | 89128 | — |
| Icahn School of Medicine-Mt. Sinai | New York | New York | 10029 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| Metrolina Nephrology Associates | Charlotte | North Carolina | 28204 | — |
| Brookview Hills Research Associates, LLC | Winston-Salem | North Carolina | 27103 | — |
| University of Cincinnati Physicians Company, LLC | Cincinnati | Ohio | 45219 | — |
| Cincinnati VA Medical Center | Cincinnati | Ohio | 45220 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Texas Tech University Health Science Center | Amarillo | Texas | 79106 | — |
| Texas Kidney Institute (Neprhotex Research Group) | Dallas | Texas | 75231 | — |
| University of Wisconsin Wisconsin Dialysis Institute | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 26 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02633046, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 3, 2021 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02633046 live on ClinicalTrials.gov.